Add to ORKGIntroduction: Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic review is to investigate whether high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) in patients with metastatic RMS has additional benefit or harm compared to standard chemotherapy
Abstract Purpose Final results are presented from two consecutive European studies for patients wit...
BACKGROUND: Rhabdomyosarcoma (RMS) is an aggressive malignancy, and 20% of children present with met...
The Children\u27s Oncology Group (COG) uses Clinical Group (CG) and modified Tumor Node Metastasis (...
Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic re...
PURPOSE: Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents th...
AIM: The RMS4.99 study was designed to explore the role of multiple sequential high-dose chemotherap...
Regardless of improvement in cure of Rhabdomyosarcoma (RMS), the results in treatment of advanced st...
<p>Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, represents a formi...
BACKGROUND Pleomorphic rhabdomyosarcoma (RMS) is a rare sub-type of RMS. Optimal treatment remain...
Rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children, is cured with conventional ...
Rhabdomyosarcoma (RMS) is a muscle-derived tumor and is the most common pediatric soft tissue sarcom...
Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm comprised of cells derived from the ...
Rhabdomyosarcoma (RMS) is a soft tissue sarcoma. The primary tumor is most commonly localized in the...
PURPOSE Pleomorphic rhabdomyosarcoma (RMS) represents a rare sarcoma subtype of the adult populat...
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence that incl...
Abstract Purpose Final results are presented from two consecutive European studies for patients wit...
BACKGROUND: Rhabdomyosarcoma (RMS) is an aggressive malignancy, and 20% of children present with met...
The Children\u27s Oncology Group (COG) uses Clinical Group (CG) and modified Tumor Node Metastasis (...
Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic re...
PURPOSE: Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents th...
AIM: The RMS4.99 study was designed to explore the role of multiple sequential high-dose chemotherap...
Regardless of improvement in cure of Rhabdomyosarcoma (RMS), the results in treatment of advanced st...
<p>Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, represents a formi...
BACKGROUND Pleomorphic rhabdomyosarcoma (RMS) is a rare sub-type of RMS. Optimal treatment remain...
Rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children, is cured with conventional ...
Rhabdomyosarcoma (RMS) is a muscle-derived tumor and is the most common pediatric soft tissue sarcom...
Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm comprised of cells derived from the ...
Rhabdomyosarcoma (RMS) is a soft tissue sarcoma. The primary tumor is most commonly localized in the...
PURPOSE Pleomorphic rhabdomyosarcoma (RMS) represents a rare sarcoma subtype of the adult populat...
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence that incl...
Abstract Purpose Final results are presented from two consecutive European studies for patients wit...
BACKGROUND: Rhabdomyosarcoma (RMS) is an aggressive malignancy, and 20% of children present with met...
The Children\u27s Oncology Group (COG) uses Clinical Group (CG) and modified Tumor Node Metastasis (...